Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Trudy N Small; Ann A. Jakubowski; Juliet N Barker; Nancy A. Kernan; Susan E Prockop; Christine Scura Iovino; LeStrange Nicole; Miguel-Angel Perales; Hugo Castro-Malaspina; Guenther Koehne; Sergio Giralt; Esperanza B Papadopoulos

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Trudy N Small, Ann A. Jakubowski, Juliet N Barker, Nancy A. Kernan, Susan E Prockop, Christine Scura Iovino, LeStrange Nicole, Miguel-Angel Perales, Hugo Castro-Malaspina, Guenther Koehne, Sergio Giralt, Esperanza B Papadopoulos

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - Nov 18 2011
Event	Blood - Duration: Jan 1 2020 → …

Conference

Conference	Blood
Period	1/1/20 → …

Disciplines

Medicine and Health Sciences
Immunology and Infectious Disease

Cite this

Small, T. N., Jakubowski, A. A., Barker, J. N., Kernan, N. A., Prockop, S. E., Iovino, C. S., Nicole, L., Perales, M.-A., Castro-Malaspina, H., Koehne, G., Giralt, S., & Papadopoulos, E. B. (2011). Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT). Blood.

@conference{9c30f23f46984cd49f82ac72b7f6429f,

title = "Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)",

author = "Small, {Trudy N} and Jakubowski, {Ann A.} and Barker, {Juliet N} and Kernan, {Nancy A.} and Prockop, {Susan E} and Iovino, {Christine Scura} and LeStrange Nicole and Miguel-Angel Perales and Hugo Castro-Malaspina and Guenther Koehne and Sergio Giralt and Papadopoulos, {Esperanza B}",

note = "Abstract 3037 In 2009, the Center for International Blood and Marrow Transplant Research (CIBMTR) published an updated, unified international set of post HCT vaccine guidelines which for the first time recommended vaccinating all patients with the protein conjugated pneumococcal vaccine (PCV7), rather than the pure polysaccharide vaccine PPV23, which is poorly immunogenic in this patient population.; Blood ; Conference date: 01-01-2020",

year = "2011",

month = nov,

day = "18",

language = "American English",

}

TY - CONF

T1 - Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

AU - Small, Trudy N

AU - Jakubowski, Ann A.

AU - Barker, Juliet N

AU - Kernan, Nancy A.

AU - Prockop, Susan E

AU - Iovino, Christine Scura

AU - Nicole, LeStrange

AU - Perales, Miguel-Angel

AU - Castro-Malaspina, Hugo

AU - Koehne, Guenther

AU - Giralt, Sergio

AU - Papadopoulos, Esperanza B

N1 - Abstract 3037 In 2009, the Center for International Blood and Marrow Transplant Research (CIBMTR) published an updated, unified international set of post HCT vaccine guidelines which for the first time recommended vaccinating all patients with the protein conjugated pneumococcal vaccine (PCV7), rather than the pure polysaccharide vaccine PPV23, which is poorly immunogenic in this patient population.

PY - 2011/11/18

Y1 - 2011/11/18

UR - http://www.bloodjournal.org/content/118/21/3037?sso-checked=true

M3 - Presentation

T2 - Blood

Y2 - 1 January 2020

ER -

Safety and Immunogenicity of the 13-Valent Protein-Conjugated Pneumococcal Vaccine(PCV13) Following Related and Unrelated Hematopoietic Stem Cell Transplantation (HCT)

Conference

Disciplines

Other files and links

Cite this